TERAFERO: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
TERAFERO
Largest movements
- Receivables within one year -€14,397
down €14,397 (-86.9%), from €16,575 to €2,178
of which Other amounts receivable: -€15,960
- Deferred charges and accrued income -€7,785
no longer reported in 2025 (was €7,785)
- Profit (loss) carried forward -€24,589
down €24,589 (-8.0%), from -€305,480 to -€330,069
- Other debts +€2,715
up €2,715 (+0.9%), from €309,448 to €312,164
- Accrued charges and deferred income -€336
down €336 (-17.9%), from €1,876 to €1,540
- Other operating charges +€15,512
up €15,512 (+2,622%), from €592 to €16,104
- Financial charges +€7,812
up €7,812 (+5,208,173%), from €0 to €7,812
- Gross operating margin +€1,960
up €1,960 (+74.5%), from -€2,632 to -€672
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €24,444 | €2,235 | -€22,209 | -90.9% |
| Current assets | 29/58 | €24,444 | €2,235 | -€22,209 | -90.9% |
| Amounts receivable within one year | 40/41 | €16,575 | €2,178 | -€14,397 | -86.9% |
| Trade receivables | 40 | €615 | €2,178 | +€1,563 | +254% |
| Other amounts receivable | 41 | €15,960 | - | -€15,960 | |
| Cash at bank and in hand | 54/58 | €84 | €57 | -€27 | -32.4% |
| Deferred charges and accrued income | 490/1 | €7,785 | - | -€7,785 | |
| Total equity and liabilities | 10/49 | €24,444 | €2,235 | -€22,209 | -90.9% |
| Equity | 10/15 | -€286,880 | -€311,469 | -€24,589 | -8.6% |
| Contributions | 10/11 | €18,600 | €18,600 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€305,480 | -€330,069 | -€24,589 | -8.0% |
| Amounts payable | 17/49 | €311,324 | €313,703 | +€2,380 | +0.8% |
| Amounts payable within one year | 42/48 | €309,448 | €312,164 | +€2,715 | +0.9% |
| Other amounts payable | 47/48 | €309,448 | €312,164 | +€2,715 | +0.9% |
| Accrued charges and deferred income | 492/3 | €1,876 | €1,540 | -€336 | -17.9% |
| Other operating charges | 640/8 | €592 | €16,104 | +€15,512 | +2,622% |
| Gross operating margin | 9900 | -€2,632 | -€672 | +€1,960 | +74.5% |
| Operating profit (loss) | 9901 | -€3,223 | -€16,776 | -€13,553 | -420% |
| Financial charges | 65/66B | €0 | €7,812 | +€7,812 | +5,208,173% |
| Recurring financial charges | 65 | €0 | €7,812 | +€7,812 | +5,208,173% |
| Profit (loss) for the period before taxes | 9903 | -€3,224 | -€24,589 | -€21,365 | -663% |
| Profit (loss) for the period | 9904 | -€3,224 | -€24,589 | -€21,365 | -663% |
| Profit (loss) for the period to be appropriated | 9905 | -€3,224 | -€24,589 | -€21,365 | -663% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 15 October 2026 via checked.be.